EYA2 and familial pancreatic carcinoma: Overexpression of EYA2 has been observed in epithelial ovarian cancer [9], lung adenocarcinoma [10] and breast cancer [11]; silencing of EYA2 gene expression has been observed in colorectal cancer [12] and pancreatic cancer [13].